235 related articles for article (PubMed ID: 34540202)
1. Case Report: PsAPSASH syndrome: an alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumab.
Nikolakis G; Kreibich K; Vaiopoulos A; Kaleta K; Talas J; Becker M; Zouboulis CC
F1000Res; 2021; 10():381. PubMed ID: 34540202
[TBL] [Abstract][Full Text] [Related]
2. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.
Vinkel C; Thomsen SF
Int J Dermatol; 2017 Aug; 56(8):811-818. PubMed ID: 28345207
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis Suppurativa-Related Autoinflammatory Syndromes: An Updated Review on the Clinics, Genetics, and Treatment of Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PASH), Pyogenic Arthritis, Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PAPASH), Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO), and Rarer Forms.
Maronese CA; Moltrasio C; Marzano AV
Dermatol Clin; 2024 Apr; 42(2):247-265. PubMed ID: 38423685
[TBL] [Abstract][Full Text] [Related]
4. Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis.
Niv D; Ramirez JA; Fivenson DP
JAAD Case Rep; 2017 Jan; 3(1):70-73. PubMed ID: 28203623
[No Abstract] [Full Text] [Related]
5. Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review.
Huang J; Tsang LS; Shi W; Li J
Front Med (Lausanne); 2022; 9():856786. PubMed ID: 35402426
[TBL] [Abstract][Full Text] [Related]
6. Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways.
Satoh TK
J Dermatol; 2024 Feb; 51(2):160-171. PubMed ID: 38031879
[TBL] [Abstract][Full Text] [Related]
7. Ancient friends, revisited: Systematic review and case report of pyoderma gangrenosum-associated autoinflammatory syndromes.
Saternus R; Schwingel J; Müller CSL; Vogt T; Reichrath J
J Transl Autoimmun; 2020; 3():100071. PubMed ID: 33305249
[TBL] [Abstract][Full Text] [Related]
8. Phenotypes and Pathophysiology of Syndromic Hidradenitis Suppurativa: Different Faces of the Same Disease? A Systematic Review.
Nikolakis G; Kaleta KP; Vaiopoulos AG; Wolter K; Baroud S; Wojas-Pelc A; Zouboulis CC
Dermatology; 2021; 237(5):673-697. PubMed ID: 32942279
[TBL] [Abstract][Full Text] [Related]
9. Renal involvement as a potential feature of pyogenic arthritis, pyoderma gangrenosum, and acne syndrome with E250K mutation of PSTPIP1 gene.
Zhao R; Novice T; Konda S
JAAD Case Rep; 2023 Feb; 32():48-51. PubMed ID: 36660269
[No Abstract] [Full Text] [Related]
10. PAPA spectrum disorders.
Genovese G; Moltrasio C; Garcovich S; Marzano AV
G Ital Dermatol Venereol; 2020 Oct; 155(5):542-550. PubMed ID: 32618443
[TBL] [Abstract][Full Text] [Related]
11. PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa.
Garcovich S; Genovese G; Moltrasio C; Malvaso D; Marzano AV
Clin Dermatol; 2021; 39(2):240-247. PubMed ID: 34272017
[TBL] [Abstract][Full Text] [Related]
12. Successful combined antibiotic therapy with oral clindamycin and oral rifampicin for pyoderma gangrenosum in patient with PASH syndrome.
Lamiaux M; Dabouz F; Wantz M; Lebas D; Lasek A; Courivaud D; Modiano P
JAAD Case Rep; 2018 Jan; 4(1):17-21. PubMed ID: 29296643
[No Abstract] [Full Text] [Related]
13. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.
Bruzzese V
J Clin Rheumatol; 2012 Dec; 18(8):413-5. PubMed ID: 23188209
[TBL] [Abstract][Full Text] [Related]
14. Recognizing syndromic hidradenitis suppurativa: a review of the literature.
Gasparic J; Theut Riis P; Jemec GB
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1809-1816. PubMed ID: 28696038
[TBL] [Abstract][Full Text] [Related]
15. Secukinumab in the treatment of hidradenitis suppurativa.
Snyder CL; Gibson RS; Porter ML; Kimball AB
Immunotherapy; 2023 Dec; 15(17):1449-1457. PubMed ID: 37840286
[TBL] [Abstract][Full Text] [Related]
16. Biology of Interleukin-17 and Novel Therapies for Hidradenitis Suppurativa.
Sabat R; Gudjonsson JE; Brembilla NC; van Straalen KR; Wolk K
J Interferon Cytokine Res; 2023 Dec; 43(12):544-556. PubMed ID: 37824200
[TBL] [Abstract][Full Text] [Related]
17. PAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment.
Cugno M; Borghi A; Marzano AV
Am J Clin Dermatol; 2017 Aug; 18(4):555-562. PubMed ID: 28236224
[TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum and suppurative hidradenitis association, overlap or spectrum of the same disease? Case report and discussion.
Turcu G; Ioana Nedelcu R; Teodora Nedelcu I; Hodorogea A; Balaban M; Brinzea A; Nichita L; Gabriela Popp C; Andrada Zurac S; Theodor Andrei R
Exp Ther Med; 2020 Jul; 20(1):38-41. PubMed ID: 32508990
[TBL] [Abstract][Full Text] [Related]
19. Whole-Exome Sequencing in 10 Unrelated Patients with Syndromic Hidradenitis Suppurativa: A Preliminary Step for a Genotype-Phenotype Correlation.
Marzano AV; Genovese G; Moltrasio C; Tricarico PM; Gratton R; Piaserico S; Garcovich S; Boniotto M; Brandão L; Moura R; Crovella S
Dermatology; 2022; 238(5):860-869. PubMed ID: 35034021
[TBL] [Abstract][Full Text] [Related]
20. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome.
Braun-Falco M; Kovnerystyy O; Lohse P; Ruzicka T
J Am Acad Dermatol; 2012 Mar; 66(3):409-15. PubMed ID: 21745697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
